Scott A. Waldman, MD, PhD, Co-Leader of the Gastrointestinal Cancer Program at the Sidney Kimmel Cancer Center at Jefferson and Chair of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been named a Fellow of the National Academy of Inventors (NAI).
Waldman is a leader in clinical pharmacology, whose groundbreaking research has led to multi-institutional clinical trials examining the utility of GCC as a molecular marker for treatment and prevention of gastrointestinal cancers.
Election to NAI Fellow status is the highest professional accolade bestowed solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society.
Waldman is the recipient of numerous honors and awards including the Reynold Spector Award in Clinical Pharmacology from the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the Rawls-Palmer Progress in Medicine Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He holds more than 40 U.S. patents and more than 60 foreign patents that have been licensed to five companies. Waldman is also a founder of Targeted Diagnostics & Therapeutics, Inc.
He has published more than 300 articles, books, and book chapters and serves as editor for Clinical Pharmacology & Therapeutics and Biomarkers in Medicine. Waldman is a Fellow of the American College of Clinical Pharmacology and the American Heart Association.
With the election of the 2017 class, there are now 912 NAI Fellows, representing over 250 research universities and governmental and nonprofit research institutes. The 2017 Fellows are named inventors on nearly 6,000 issued U.S. patents, bringing the collective patents held by all NAI Fellows to more than 32,000 issued U.S. patents.
On April 5, 2018, the 2017 NAI Fellows will be inducted as part of the Seventh Annual NAI Conference of the National Academy of Inventors at the Mayflower Hotel, Autograph Collection in Washington, D.C. Andrew H. Hirshfeld, U.S. Commissioner for Patents, will provide the keynote address for the induction ceremony.
Those elected to the rank of NAI Fellow are named inventors on U.S. patents and were nominated by their peers for outstanding contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.